1. Naka N., Ohsawa M., Tomita Y., et al: Prognostic factors in angiosarcoma: a multivariate analysis of 55 cases. J Surg Oncol 61. 170-176.1996;
2. Mark R.J., Poen J.C., Tran L.M., et al: Angiosarcoma. A report of 67 patients and a review of the literature. Cancer 77. 2400-2406.1996;
3. Rouhani P., Fletcher C.D., Devesa S.S., et al: Cutaneous soft tissue sarcoma incidence patterns in the U.S.: an analysis of 12,114 cases. Cancer 113. 616-627.2008;
4. Torosian M.H., Friedrich C., Godbold J., et al: Soft-tissue sarcoma: initial characteristics and prognostic factors in patients with and without metastatic disease. Semin Surg Oncol 4. 13-19.1988;
5. Coindre J.M., Terrier P., Guillou L., et al: Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group. Cancer 91. 1914-1926.2001;
6. Penel N., Grosjean J., Robin Y.M., et al: Frequency of certain established risk factors in soft tissue sarcomas in adults: a prospective descriptive study of 658 cases. Sarcoma 2008. 459386.2008;
7. Fury M.G., Antonescu C.R., Van Zee K.J., et al: A 14-year retrospective review of angiosarcoma: clinical characteristics, prognostic factors, and treatment outcomes with surgery and chemotherapy. Cancer J 11. 241-247.2005;
8. Fayette J., Martin E., Piperno-Neumann S., et al: Angiosarcomas, a heterogeneous group of sarcomas with specific behavior depending on primary site: a retrospective study of 161 cases. Ann Oncol 18. 2030-2036.2007;
9. Abraham J.A., Hornicek F.J., Kaufman A.M., et al: Treatment and outcome of 82 patients with angiosarcoma. Ann Surg Oncol 14. 1953-1967.2007;
10. Virtanen , Pukkala E., Auvinen A.: Angiosarcoma after radiotherapy: a cohort study of 332,163 Finnish cancer patients. Br J Cancer 97. 115-117.2007;
11. Woodward A.H., Ivins J.C., Soule E.H.: Lymphangiosarcoma arising in chronic lymphedematous extremities. Cancer 30. 562-572.1972;
12. Bosetti C., La Vecchia C., Lipworth L., et al: Occupational exposure to vinyl chloride and cancer risk: a review of the epidemiologic literature. Eur J Cancer Prev 12. 427-430.2003;
13. Lipshutz G.S., Brennan T.V., Warren R.S.: Thorotrast-induced liver neoplasia: a collective review. J Am Coll Surg 195. 713-718.2002;
14. Huang J., Mackillop W.J.: Increased risk of soft tissue sarcoma after radiotherapy in women with breast carcinoma. Cancer 92. 172-180.2001;
15. Sordillo P.P., Chapman R., Hajdu S.I., et al: Lymphangiosarcoma. Cancer 48. 1674-1679.1981;
16. Muller R., Hajdu S.I., Brennan M.F.: Lymphangiosarcoma associated with chronic filarial lymphedema. Cancer 59. 179-183.1987;
17. Locker G.Y., Doroshow J.H., Zwelling L.A., et al: The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature. Medicine (Baltimore) 58. 48-64.1979;
18. Ben-Izhak O., Kerner H., Brenner B., et al: Angiosarcoma of the colon developing in a capsule of a foreign body. Report of a case with associated hemorrhagic diathesis. Am J Clin Pathol 97. 416-420.1992;
19. Weiss W.M., Riles T.S., Gouge T.H., et al: Angiosarcoma at the site of a Dacron vascular prosthesis: a case report and literature review. J Vasc Surg 14. 87-91.1991;
20. McDonald D.J., Enneking W.F., Sundaram M.: Metal-associated angiosarcoma of bone: report of two cases and review of the literature. Clin Orthop Relat Res 396. 206-214.2002;
21. Fanburg J.C., Meis-Kindblom J.M., Rosenberg A.E.: Multiple enchondromas associated with spindle-cell hemangioendotheliomas. An overlooked variant of Maffucci's syndrome. Am J Surg Pathol 19. 1029-1038.1995;
22. Weiss S.W., Goldblum J.R.: Enzinger and Weiss's Soft Tissue Tumors. Mosby-Year Book, Inc,St. Louis, MO2008.
23. West J.G., Weitzel J.N., Tao M.L., et al: BRCA mutations and the risk of angiosarcoma after breast cancer treatment. Clin Breast Cancer 8. 533-537.2008;
24. Penel N., Bui B.N., Bay J.O., et al: Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study. J Clin Oncol 26. 5269-5274.2008;
25. Penel N., Van Glabbeke M., Marreaud S., et al: Testing new regimens in patients with advanced soft tissue sarcoma: analysis of publications from the last 10 years. Ann Oncol 22. 1266-1272.2011;
26. Schlemmer M., Reichardt P., Verweij J., et al: Paclitaxel in patients with advanced angiosarcomas of soft tissue: a retrospective study of the EORTC soft tissue and bone sarcoma group. Eur J Cancer 44. 2433-2436.2008;
27. Ray-Coquard I., Italiano A., Bompas E., et al: Sorafenib for patients with advanced angiosarcoma: a phase II Trial from the French Sarcoma Group (GSF/GETO). Oncologist 17. 260-266.2012;
28. Maki R.G., D'Adamo D.R., Keohan M.L., et al: Phase II study of sorafenib in patients with metastatic or recurrent sarcomas. J Clin Oncol 27. 3133-3140.2009;
29. Park M.S., Ravi V., Araujo D.M.: Inhibiting the VEGF-VEGFR pathway in angiosarcoma, epithelioid hemangioendothelioma, and hemangiopericytoma/solitary fibrous tumor. Curr Opin Oncol 22. 351-355.2010;
30. Agulnik M., Yarber J.L., Okuno S.H., et al: An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas. Ann Oncol 24. 257-263.2013
Comentarios
Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.